Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-16

FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ribavirin from Aurobindo Pharma Limited, authorizing the generic ribavirin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

SUPPL AP for RIBAVIRIN (RIBAVIRIN)